Cartesian Therapeutics Inc (RNAC)

Working Capital Ratio

41.76%

Quarterly · Period ending:

RNAC logo

RNAC Working Capital Ratio

Latest reported38.57%
RNAC FY Working Capital Ratio (44.45% → 38.57%)
High-resolution chart · PNG

RNAC working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cartesian Therapeutics Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
38.5745%
44.5149%
7.3824%
74.1841%
45.153%
42.1894%
61.9912%
15.5838%
86.7527%
81.8692%
73.8441%
44.4529%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.